Francisco Torrens | Pharmacology | Breakthrough Research Award

Breakthrough Research Award

             Francisco Torrens
Affiliation Universitat de València
Country Spain
Scopus ID 56924529100
Documents 255
Citations 4,190
h-index 33
Subject Area Pharmacology
Event International Research Awards
ORCID 0000-0003-1737-2321

Francisco Torrens

Universitat de València, Spain

Francisco Torrens is a researcher affiliated with Universitat de València whose scholarly activities have contributed to pharmacology and related interdisciplinary scientific fields. His publication record, citation performance, and internationally indexed research profile demonstrate sustained academic engagement and measurable scientific influence. These achievements support recognition within competitive research award programs and international scholarly evaluations.[1]

Abstract

Francisco Torrens has established a distinguished academic profile through sustained research activity, international publications, and measurable scientific influence within pharmacology and interdisciplinary computational sciences. His Scopus-indexed record includes 255 publications, more than 4,190 citations, and an h-index of 33, reflecting consistent scholarly productivity and broad research visibility. His work has supported scientific understanding through theoretical investigations, collaborative studies, and methodological developments that contribute to international research communities. These achievements demonstrate academic excellence, research continuity, and global scholarly recognition, making his profile well aligned with the objectives and evaluation standards of the Breakthrough Research Award.[1][2]

Keywords

Pharmacology, Computational Chemistry, Molecular Modeling, Drug Discovery, Scientific Research, Scopus Author, Citation Impact, International Research Awards, Breakthrough Research Award, Research Excellence.

Introduction

Scientific recognition is founded upon sustained research productivity, scholarly quality, and measurable academic influence. Francisco Torrens has developed an established research career supported by extensive publications, international collaborations, and consistent citation performance that reflects the relevance of his scientific contributions within pharmacology and computational research disciplines.[1]

Research Profile

Based at Universitat de València, Francisco Torrens has maintained an internationally visible academic profile indexed by Scopus and ORCID. His publication metrics demonstrate long-term scholarly engagement while supporting interdisciplinary research activities across pharmacology, computational chemistry, molecular science, and related analytical methodologies.[1]

Research Contributions

His research contributions emphasize theoretical investigations, computational approaches, molecular characterization, and scientific modeling that enhance understanding of biologically relevant systems. Through peer-reviewed publications and collaborative research, he has contributed valuable knowledge supporting evidence-based scientific advancement across multiple research domains.[2]

Publications

Francisco Torrens has authored or co-authored 255 Scopus-indexed publications that collectively demonstrate consistent scholarly productivity. His publications have appeared in internationally recognized scientific journals, contributing to ongoing developments in pharmacology, computational chemistry, molecular science, and interdisciplinary biomedical research.[1]

Research Impact

With more than 4,190 citations and an h-index of 33, his research demonstrates sustained academic influence across international scientific literature. These bibliometric indicators illustrate the continued relevance, visibility, and utilization of his published work within the global research community.[3]

Award Suitability

The Breakthrough Research Award recognizes researchers demonstrating significant scholarly achievement, measurable scientific impact, and continued research excellence. Francisco Torrens satisfies these evaluation criteria through his publication record, citation performance, interdisciplinary collaborations, and internationally recognized academic profile.[4]

Conclusion

Francisco Torrens represents an accomplished researcher whose scholarly record reflects sustained productivity, scientific influence, and international visibility. His research achievements, recognized publication metrics, and established academic profile support his suitability for consideration within the International Research Awards and similar programs recognizing research excellence.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Francisco Torrens. Author ID 56924529100. Scopus.
    https://www.scopus.com/pages/authors/56924529100
  2. ORCID. (n.d.). ORCID author details: Francisco Torrens.
    https://orcid.org/0000-0003-1737-2321
  3. International Research Awards. (n.d.). Breakthrough Research Award.
    https://researchawards.net/
  4. Sandoval-Vásquez, C., Cárcamo, I., Lagos, P., Muñoz, A., Zavala, F., Colil, V., Villagrán-Silva, F., Vásquez-Carrasco, E., Hernandez-Martinez, J., Valdés-Badilla, P., Torrens, F., Fincheira, P., & Sepúlveda, P. (2025). Effectiveness of drug-loaded poly(ethylene glycol) and poly(lactic-co-glycolic-acid) nanoparticles in the in vitro treatment of breast cancer: A systematic review. Frontiers in Pharmacology, 16, 1710176.
    https://doi.org/10.3389/fphar.2025.1710176
  5. Canizares-Carmenate, Y., Perez-Gimenez, F., Diaz-Amador, R., Torrens, F., & Castillo-Garit, J. A. (2025). Discovery of diphenylsilane compounds as potential inhibitors of Zn-metalloproteinase thermolysin using artificial neural networks. Current Computer-Aided Drug Design. Advance online publication.
    https://doi.org/10.2174/0115680266369656250428053942

Li-Na Gao | Pharmacology | Best Researcher Award | 13230

Assoc. Prof. Dr. Li-Na Gao | Pharmacology | Best Researcher Award 

Assoc. Prof. Dr. Li-Na Gao, Jining Medical University, China

Assoc. Prof. Dr. Li-Na Gao is a postdoctoral fellow at the University of British Columbia and an academic leader at Jining Medical University, China. Her research focuses on neuropsychopharmacology and anti-inflammatory immune pharmacology of traditional Chinese medicine (TCM). She has led multiple research projects, published over 40 academic papers (H-index: 21, citations: 1,900+), and collaborates on innovative TCM drug development. Dr. Gao holds key editorial and professional memberships, contributing significantly to TCM research, particularly in cardiovascular and cerebrovascular diseases, inflammation, and gut-brain interaction. She has secured ¥1.04 million in research funding and actively promotes TCM modernization.

Profile

Scopus

Early Academic Pursuits 🎓

Dr. Li-Na Gao embarked on her academic journey with a strong foundation in Traditional Chinese Medicine (TCM), leading her to become an esteemed researcher and educator in the field. Her passion for TCM and its applications in modern pharmacology inspired her to pursue advanced studies. After earning her Ph.D., she further honed her expertise as a postdoctoral fellow at the University of British Columbia. Her early academic years were marked by rigorous research into the pharmacological mechanisms of TCM, setting the stage for her later contributions to neuropsychopharmacology and inflammatory immune pharmacology.

Professional Endeavors 💼

Currently serving as an Associate Professor at Jining Medical University, Dr. Gao plays a crucial role in advancing the field of TCM. She has established herself as an academic leader in key TCM disciplines in Shandong Province. With her extensive background, she has been instrumental in mentoring students, conducting cutting-edge research, and collaborating with renowned institutions. Her work extends beyond academia, encompassing consultancy projects and significant contributions to the development of TCM-based treatments.

Contributions and Research Focus 📝

Dr. Gao’s research is primarily centered on the neuropsychopharmacology and inflammatory immune pharmacology of TCM. She has made significant contributions in the following areas:

  • Heart, Brain, and Intestine Disease Correlation: She has explored the scientific underpinnings of TCM theories, such as “the heart dominates the mind, and the small intestine is exterior to interior.”
  • Inflammatory Metabolic Damage and Depression: She has pioneered the understanding that inflammatory metabolic damage is a key pathological mechanism of depression and its co-occurrence with somatic diseases.
  • Intestinal-Brain Communication: Her work has identified TLR4 as the critical “bridge molecule” in mediating inflammatory metabolic disorders, enhancing our understanding of gut-brain interactions.
  • Secondary Development of TCM: She has provided significant insights into the mechanisms of Gegen Qinlian decoction, Scrophularia ningpoensis Hemsl., puerarin, and glycyrrhizic acid, thereby enhancing their applications in modern medicine.

Accolades and Recognition 🏆

Dr. Gao has been recognized for her outstanding contributions to research and academia. She has published over 40 academic papers, boasting an H-index of 21 and more than 1,900 citations. Her editorial appointments include:

  • Visiting Deputy Editor-in-Chief of Frontiers in Pharmacology (2021–Present)
  • Youth Editorial Board Member of Acupuncture and Herb Medicine (2022–2024)
  • Youth Editorial Board Member of Advanced Gut & Microbiome Research (2022–2023)
  • Youth Editorial Board Member of Tianjin Traditional Chinese Medicine (2023–Present)

She has also been an integral part of major collaborative research projects, including a 1.04 million RMB-funded project on acute and chronic inflammatory diseases in cooperation with Rizhao Hospital of Traditional Chinese Medicine.

Impact and Influence 🌍

Dr. Gao’s research has had a profound impact on the global TCM community. Her contributions extend beyond research papers and patents to shaping policies and educational curriculums. As a standing committee member of multiple prestigious organizations, she has influenced the standardization and modernization of TCM research. Her work in bridging the gap between traditional medicine and modern pharmacology has helped in integrating TCM into contemporary medical practices.

Publication Top Notes

Author: Xu, D., Gao, L.-N., Song, X.-J., Cui, Y.-L., Wang, Q.

Journal: Nanobiotechnology

Year: 2023

Author: Huang, M., He, Y., Tian, L., Gao, S., Yu, C.

Journal: Affective Disorders

Year: 2023

Polysaccharides from Scrophularia ningpoensis Hemsl. improve reserpine-induced depression-like behavior by inhibiting HTR2A/HTR2C mediated AKT/GSK3β/β-catenin/CBP/BDNF signalling

Author: Ruhui Shen, Jian’an Wang, Yijin Zhao, Zhaojin Dang , Ke Zhang, Ming Li , Qian Yang , Li-Na Gao

Journal: Biological Molecules

Year: 2025